SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

IOL Chemicals & Pharmaceuticals informs about clarification on price movement

21 Apr 2023 Evaluate
With reference to mail Ref No. L/SURV/ONL/PV/MG/2023-2024/3272 dated 20th April 2023, IOL Chemicals & Pharmaceuticals has submitted that there is no such announcement or price sensitive information, which is pending to be intimated by the Company to the Stock Exchange that have a bearing on the operation /performance of the Company. The Company has further informed and clarified that all the information furnished by the Company is in public domain and Company will keep the Stock Exchanges duly informed of all the price sensitive information(s) in compliance with SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

IOL Chem & Pharma Share Price

91.16 5.66 (6.62%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×